Yanli Nie

机构：Annoroad Gene Technology (China), Hubei Cancer Hospital, Wuhan University of Science and Technology, Huazhong University of Science and Technology

发表论文 21 篇 · 总被引 583 次 · h-index 8

代表论文

• Hospital survey on patient safety culture in China (2013 · BMC Health Services Research · 被引 426)
• Integration of multiomics features for blood-based early detection of colorectal cancer (2024 · Molecular Cancer · 被引 35)
• Manganese Dioxide/Gold-based Active Tumor Targeting Nanoprobes for Enhancing Photodynamic and Low-Temperature-Photothermal Combination Therapy in Lung Cancer (2023 · ACS Applied Materials & Interfaces · 被引 24)
• Delisheng, a Chinese medicinal compound, exerts anti-proliferative and pro-apoptotic effects on HepG2 cells through extrinsic and intrinsic pathways (2009 · Molecular Biology Reports · 被引 18)
• Predictive biomarkers and new developments of immunotherapy in gastric cancer: a 2023 update. (2023 · PubMed · 被引 15)
• WASF3 Knockdown Sensitizes Gastric Cancer Cells to Oxaliplatin by Inhibiting ATG12-Mediated Autophagy (2020 · The American Journal of the Medical Sciences · 被引 14)